Posts Tagged ‘ paxil ’
Paxil Birth Defects: Baby Beware!
July 20th, 2009. By LucyC
Depression during pregnancy is a health risk not only for the mother, but also for her baby, yet it’s not widely publicized. According to information on the March of Dimes website—the March of Dimes being a leading non-profit organization for pregnancy and baby health—two of every 10 women experience symptoms of depression during pregnancy. That’s considerable.
So where’s the health risk to the baby? You get a prescription for an antidepressant and hope for the best, right? Wrong. The fallback treatment for depression has become antidepressant drugs, the most common type being selective serotonin reuptake inhibitors or SSRIs. SSRIs, such as Paxil (paroxetine) which are associated with serious cardiovascular malformations, primarily ventricular septal defects (VSDs) and atrial septal defects (ASDs). The risk for these birth defects is so serious that GlaxoSmithKline’s (the maker of Paxil) own publicly available literature states:
For women who intend to become pregnant or are in their first trimester of pregnancy, paroxetine should only be used after consideration of the other available treatment options. Read the rest of this entry »
Grassley Seeks More Info on Conflict of Interest Policies at Medical Schools
June 25th, 2009. By Evelyn Pringle
In a June 24, 2009 letter, Senator Chuck Grassley asked 23 medical schools for information about their policies for conflicts of interest and requirements for disclosure of financial relationships between faculty members and the pharmaceutical industry.
“I recently learned from an American Medical Student Association report, AMSA PharmFree Scorecard 2009, that your institution either had “no response” or “declined to submit policies” when asked to supply conflicts of interest policies,” he said in the letter.
Grassley asked the Universities to respond by no later than July 15, 2009.
Of the 149 schools asked, 126 provided information to the AMSA. The Scorecard 2009 was released on June 16, 2009. Thirty-five schools, or 23%, received an F. Seventeen got a D, 18 received a C, 36 were graded B, and only 9 schools received an A.
“There’s a lot of skepticism about financial relationships between doctors and drug companies,” Grassley said in a press release. “Disclosure of those ties would help to build confidence that there’s nothing to hide.”
“Requiring disclosure is a common sense reform based on the public dollars and public trust at stake in medical training, medical research and the practice of medicine,” he added. Read the rest of this entry »
Pharma Pill Pushers Use Suicide Ruse – Again
June 4th, 2009. By Evelyn Pringle
Nearly every year, researchers on drug company payrolls publish some ridiculous study with claims that more people may be dying from suicide due to a black box warning about an increased risk of suicide in young people on the labels of SSRI and SNRI antidepressants as a ruse to increase sales of drugs.
Judging from a new study out this month, with a June 2, 2009 headline on WebMD stating: “Are Antidepressant Warnings Causing Harm?”, apparently this year is no exception even though in the US there were 164.2 million prescriptions dispensed for antidepressants in 2008, compared to 143 million in 2004, according to IMS Health, a healthcare information company.
The study, published in the Archives of General Psychiatry, claims there has been a drastic drop in the diagnosis of depression in adults and kids.
Sex and Psych Drugs – Young Couples Beware
June 2nd, 2009. By Evelyn Pringle
Although the adverse effects of women taking psychiatric drugs while pregnant related to birth defects and infant withdrawal syndrome are often discussed or reported, the serious adverse effects on the sex lives and reproductive systems of millions of young couples are rarely mentioned.
Whatever the reason, due to the ever widening marketing campaigns by the psycho-pharmaceutical industry, young people need to be warned before they get conned into taking psychiatric drugs. Read the rest of this entry »
Antidepressant Suicide Reports Continue to Mount
May 28th, 2009. By Evelyn Pringle
This week, journalist Philip Dawdy reported on the popular website Furious Seasons that Wyeth’s Effexor me-too drug Pristiq, FDA approved in early 2008, had already generated 1,272 adverse event reports in the FDA’s MedWatch system through the end of 2008, and wrote with live links to the reports:
“It’s discouraging that 17 of those reports involve completed suicides through the end of 2008. There are also 48 reports of suicidal ideation through the end of 2008.”
“That’s a lot in such a short period of time, especially considering that this drug isn’t exactly widely used,” Dawdy points out. Read the rest of this entry »
Find us on
Archive by Category
- Accidents (24)
- Airlines (9)
- Asbestos Mesothelioma (262)
- Automotive (25)
- Celebrity (14)
- Class Action (84)
- Complaints/Comments (15)
- Consumer Fraud (84)
- Contest (2)
- Court of Public Opinion (5)
- Crazy Sh*t Lawyers See (61)
- Criminal Law (4)
- Defective Products (111)
- DePuy ASR Hip Recall (2)
- Discrimination (22)
- Drugs/Medical (248)
- Elder Care Abuse (4)
- Emerging Issues (462)
- Employment (54)
- Environment (52)
- Financial (28)
- Food Illness (15)
- Human/Civil Rights (4)
- Insecurities (5)
- Insurance (16)
- Intellectual Property (16)
- Internet/E-commerce (19)
- lawsuits (161)
- Lawyers (20)
- Lawyers Giving Back (43)
- Lex Levity (10)
- Personal Injury (106)
- Pleading Ignorance (53)
- Real Estate (2)
- Recall (6)
- Scam (3)
- Securities (13)
- Settlement (81)
- Tort Reform (2)
- Totally Tortelicious (81)
- Veterans (11)
- Whistleblower (9)